Journal of vascular surgery. Venous and lymphatic disorders
-
J Vasc Surg Venous Lymphat Disord · Nov 2020
Sequential interventional therapy for Budd-Chiari syndrome associated with fresh inferior vena cava thrombosis.
Our study aimed to evaluate the safety and efficacy of sequential interventional therapy for Budd-Chiari syndrome (BCS) caused by obstruction of the inferior vena cava (IVC) with fresh thrombus in the IVC. ⋯ Sequential interventional therapy for BCS associated with fresh IVC thrombus is safe and effective.
-
J Vasc Surg Venous Lymphat Disord · Nov 2020
Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
The objective of this study was to retrospectively review the clinical and radiographic outcomes of patients with venous malformations (VMs) treated with bleomycin-polidocanol foam (BPF) sclerotherapy. ⋯ BPF sclerotherapy of VMs is safe and effective. BPF sclerotherapy can be a promising first-line treatment of VMs.
-
J Vasc Surg Venous Lymphat Disord · Nov 2020
Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Congenital vascular malformations are a heterogeneous group of lesions with the potential to cause significant lifelong morbidity in children. Diagnosis and treatment of these lesions may be complex and require a multidisciplinary approach. Sclerotherapy is widely used for the treatment of low-flow vascular malformations (LFVMs) as an alternative to surgical resection in adults; however, limited data of its use in a pediatric setting are available. The purpose of this study was to evaluate the efficacy and safety of sclerotherapy for pediatric LFVMs. ⋯ This series of pediatric LFVMs, the largest of its kind to date, demonstrates that sclerotherapy with foam-based agents effectively reduces symptoms with an acceptable rate of complications. Further study is needed to determine the optimal sclerosing agents for individual subsets of LFVMs in the pediatric population.